Health News Releases

  • Today November 13
March 04, 2025 10:49
Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX (https://www.protagonist-inc.com/)) and Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced positive top
March 03, 2025 13:20
New Bipolar Disorder Study Shows that a Ketogenic Diet Leads to Mental and Physical Health Benefits
Baszucki Group today announced a new pilot study on a ketogenic diet in bipolar disorder. “For the first time in years, I felt like my brain was finally running on the right fuel,” said one of the stu
March 03, 2025 12:00
Astria Therapeutics Initiates ALPHA-ORBIT Phase 3 Pivotal Trial of Navenibart in Hereditary Angioedema
Astria Therapeutics, Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fastriatx.com%2F&esheet=54215940&newsitemid=20250227320197&lan=en-US&anchor=Astria+Therapeutics%2C+Inc.&inde
March 03, 2025 10:40
SINOVAC Announces New Board Pursuant to Privy Council Judgment and Order
Sinovac Biotech Ltd. (NASDAQ:SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that SINOVAC has received on February 8, 2025 a formal court
February 28, 2025 16:30
Cynosure Lutronic and Amico Aesthetics Join Forces by Signing a Strategic Distribution Agreement for the Middle East
Cynosure Lutronic, a global leader in the energy-based devices market, has entered into a multi- country distribution agreement with Amico Aesthetics, a leader in providing world-class medical devices
February 28, 2025 11:25
The Estée Lauder Companies Partners with Serpin Pharma, Inc to Develop Breakthrough Skin Care Ingredients to Advance Longevity
The Estée Lauder Companies Inc. (NYSE: EL) (ELC) today announced a collaboration with biotechnology company, Serpin Pharma, that aims to explore how their anti-inflammatory research can be applied in
X-ray imaging results of D23 (Budesonide Ileum Targeted Tablet) (Graphic: Business Wire)
February 27, 2025 14:00
Triastek D23 (Budesonide Ileum Targeted Tablets) Receives Positive Clinical Results
Triastek announces that its 3D printed drug product D23 (Budesonide Ileum Targeted Tablets for the treatment of IgAN) has achieved positive results in recent clinical study. D23 is budesonide delayed-
BROADMEDI CEO Kim Sun-ae, Korea Hospital Coordinator Association President Lee Soo-jae
February 26, 2025 16:48
BROADMEDI and KHCA Sign Strategic MOU to Enhance Medical Tourism Services
BROADMEDI, a leading medical tourism platform of CREINNOS, has signed a strategic Memorandum of Understanding (MOU) with the Korea Hospital Coordinator Association (KHCA) to enhance service quality in
KEYRESEARCH’s ‘Aco-Alpha’ Sells Out in First Batch with Proprietary Technology
February 24, 2025 16:43
KEYRESEARCH Launches ‘Aco-Alpha’ Nutr Supplement for Kids and Sells Out on First Day
KEYRESEARCH, a prominent name in health, announced the successful launch of its new product, ‘Aco-Alpha,’ on the 24th. It has been sold out immediately thanks to overwhelming demand. This sellout high
Portrait: Dr. Rudolf Widmann | Member of the Board of Directors & Founder | AOP Health | Photocredit
February 23, 2025 13:20
ICC Arbitral Tribunal Rules in Favor of AOP Health in Arbitration Proceedings Pertaining to BESREMi® (Ropeginterferon alfa-2b)
Today, a tribunal under the auspices of the International Chamber of Commerce (ICC) served a partial final award in a dispute between PharmaEssentia Corp. (“PharmaEssentia”) and AOP Orphan Pharmaceuti
PelviTouch Therapy Presentation at ESSM Congress (Photo by DEKA)
February 23, 2025 11:50
Erectile Dysfunction: The PelviTouch Revolution Comes From DEKA’s Italian Technology
DEKA Laser, a subsidiary of El.En. S.p.A., a company operating in the Laser and Energy-Based Devices market, listed on Borsa Italiana’s Euronext STAR Milan (“STAR”), and a global leader in medical tec
February 23, 2025 11:15
CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients
CareDx, Inc. (Nasdaq: CDNA) - The Transplant Company™ - a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healt
Ferrer team celebrating becoming the pharmaceutical company with the highest B Corp score (Photo: Bu
February 21, 2025 10:40
Ferrer is the Highest-performing Pharmaceutical Company in the World for Social and Environmental Impact According to B Corp
Spanish pharmaceutical company Ferrer has reaffirmed its status as a B Corp, an international certification awarded to companies that operate with a business model centered on positive impact and meet
February 21, 2025 09:40
Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery
Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today announced the completion of its oversubscribed $US5.5 million Seed extension round. Enki
February 20, 2025 09:17
Parse Biosciences Launches 5 Million Cell Evercode WT Penta Kit for Single Cell Sequencing
Parse Biosciences, the leader in high-throughput single cell sequencing, today announced the launch of Evercode™ WT Penta and Penta 384, the first single cell RNA sequencing kits to profile 5 million
Italian Tennis Star Jasmine Paolini Joins Amazfit as Latest Athlete Ambassador (Photo: Business Wire
February 19, 2025 15:15
Italian Tennis Star Jasmine Paolini Joins Amazfit as Latest Athlete Ambassador
Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), today announced the signing of Italian tennis sensation and World No. 4 Jasmine Paolini as its newest global athlete
February 19, 2025 11:00
Novotech Partners with Wonju Severance Christian Hospital to Drive Clinical Research Excellence in Korea
Novotech, a global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced and novel ther
February 18, 2025 15:20
Galderma’s Nemluvio® (Nemolizumab) Granted Marketing Authorization in the United Kingdom and Switzerland for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis
Galderma today announced that the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency and Swissmedic have granted the marketing authorization of nemolizumab for the treatment of bo
Five-time Olympic Medalist and fashion icon, Gabby Thomas, is the latest ambassador to join Amazfit'
February 16, 2025 09:30
Five-Time Olympic Medalist Gabby Thomas Joins Amazfit as Athlete Ambassador
Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), is proud to announce five-time Olympic Medalist and fashion icon, Gabby Thomas, as the latest ambassador to join the
February 14, 2025 15:45
Galderma’s Nemluvio® (Nemolizumab) Approved in the European Union for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis
Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now a
*For research purposes only. Anticipated visual image of LiCellGrow. All features subject to change.
February 11, 2025 11:30
PHC and CCRM Collaborate to Develop Primary T-Cell Expansion Culture Processes to Enhance Efficiency and Improve Cell Quality
PHC Corporation has signed a Master Collaboration Agreement with CCRM to work together on the development of primary T-cell(*1) expansion culture processes that will seek to accelerate the manufacturi
February 06, 2025 09:35
Parse Biosciences Invalidates All 10x Genomics’ Patent Claims Asserted Against Its Products
Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54199035&newsitemid=20250204152815&lan=en-US&anchor=Parse+Biosciences&index=1&md
February 04, 2025 16:35
ELIQUENT Life Sciences Announces: Rob Wojciechowski Named Chief Operations Officer
ELIQUENT Life Sciences (ELIQUENT), a global regulatory, quality, and safety consulting firm, today announced the appointment of Rob Wojciechowski as Chief Operations Officer (COO). In this new role, R
GE HealthCare’s contrast media manufacturing site in Cork (Photo: Business Wire)
January 31, 2025 17:24
GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand
GE HealthCare (Nasdaq: GEHC) today announced a $138 million investment to expand its Carrigtohill, Cork contrast media fill and finish manufacturing site in Ireland. A new state-of-the-art facility on
January 31, 2025 15:37
IMCAS 2025: New Galderma Phase IIIb Data Reinforce Rapid Onset and Long-lasting Aesthetic Improvement with RelabotulinumtoxinA (Relfydess™)
Galderma (SWX:GALD), the pure-play dermatology category leader, announced today results from its new phase IIIb RELAX clinical trial demonstrating the rapid onset and the long-lasting duration of aest
25 per page50 per page75 per page100 per page